Erly Prefilled Pen

Erly is a high-potency, metabolic intervention containing Liraglutide (6 mg/ml), a specialized glucagon-like peptide-1 (GLP-1) receptor agonist. Specifically engineered for the clinical management of type 2 diabetes mellitus and chronic weight management in adults, Erly works by targeting the physiological pathways of glucose homeostasis and appetite regulation. Liraglutide acts as a potent biological analog to native GLP-1, binding to and activating the GLP-1 receptor. This targeted biochemical action provides a decisive therapeutic response to stimulate insulin secretion in a glucose-dependent manner, suppress inappropriate glucagon secretion, and delay gastric emptying, effectively stabilizing blood glycemic levels and promoting a sustained feeling of satiety.

Key Features

The prefilled pen allows for accurate and easy adjustment of the dose as prescribed.
Specifically mimics the action of natural incretin hormones to regulate blood sugar.
Promotes insulin secretion only when blood sugar levels are elevated.
Targets hunger centers in the brain to decrease cravings and support weight loss goals.
Designed for easy self-administration in the abdomen, thigh, or upper arm.

Key Ingredients

Liraglutide (6 mg/ml)
Disodium Phosphate Dihydrate
Propylene Glycol
Phenol
Water for Injection

Precautions

Must be used strictly under the supervision of an endocrinologist or qualified healthcare professional.
Not recommended for individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or MEN 2.
Discontinue use and seek immediate medical attention if you experience persistent, severe abdominal pain.
The risk of low blood sugar increases if used in combination with sulfonylureas or insulin.
Use with caution in patients with renal impairment; regular monitoring of kidney function may be required.
Erly is contraindicated during pregnancy and lactation; consult your doctor for alternative metabolic therapies.

How to Use

Administered as a subcutaneous injection in the abdomen, thigh, or upper arm. Do not inject into a vein or muscle.
Can be administered at any time of day, independent of meals, but should ideally be taken at the same time each day.
Typically started at a low dose (e.g., 0.6 mg) and increased weekly to minimize gastrointestinal side effects.
Ensure the injection pen is primed (the “flow check” symbol) before the first use of each new pen.
Store unused pens in the refrigerator (2°C to 8°C). After first use, the pen can be kept at room temperature or in the refrigerator for up to 30 days.
Always use a new sterile needle for each injection and dispose of used needles in a sharps container.

Legal Disclaimer: Erly Prefilled Pen is a prescription-only pharmaceutical product. Individual results regarding blood sugar control and weight loss may vary based on diet, exercise, and metabolic rate. This product is not a substitute for insulin in patients with type 1 diabetes. This information is for educational purposes and is not a substitute for professional medical consultation.